Search research articles
Contact Us
Filters
Showing results (511-520 of 597) with videos related to
Page
of 60
Sort By:
Ugeskrift for Laeger
|
November 5, 1979
[Reduction of mortality in acute myocardial infarction in patients treated with alprenolol. Preliminary results]
M Andersen, P Bechsgaard, J Frederiksen, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
April 1, 1997
Identification of two novel missense mutations in the human OB gene
S M Echwald, S B Rasmussen, T I Sørensen, et al.
Diabetes
|
December 10, 1997
Effect of insulin on GLUT4 cell surface content and turnover rate in human skeletal muscle as measured by the exofacial bis-mannose photolabeling technique
S Lund, G D Holman, J R Zierath, et al.
Diabetologia
|
August 1, 1997
Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3alpha and beta isoforms in patients with NIDDM
L Hansen, K C Arden, S B Rasmussen, et al.
Diabetologia
|
October 13, 2001
Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians
J Ek, G Andersen, S A Urhammer, et al.
Acta Medica Scandinavica. Supplementum
|
January 1, 1984
Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Study design, patient characteristics and conduct of the study
H J Jürgensen, M P Andersen, P Bechsgaard, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 2008
Lack of association of fatness-related FTO gene variants with energy expenditure or physical activity
T Berentzen, S I I Kring, C Holst, et al.
Diabetes, Obesity & Metabolism
|
March 30, 2007
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial
S S Lund, L Tarnow, C D A Stehouwer, et al.
Diabetes Care
|
August 1, 1990
Acute actions of sulfonylurea drugs during long-term treatment of NIDDM
O K Faber, H Beck-Nielsen, C Binder, et al.
Acta Medica Scandinavica. Supplementum
|
January 1, 1984
The effect of long-term intervention with alprenolol on mortality in definite or suspected myocardial infarction
H J Jürgensen, J Frederiksen, M P Andersen, et al.
Page
of 60
Search research articles
Search
Showing results (511-520 of 597) with videos related to
Sort By:
Page
of 60
Ugeskrift for Laeger
|
November 5, 1979
[Reduction of mortality in acute myocardial infarction in patients treated with alprenolol. Preliminary results]
M Andersen, P Bechsgaard, J Frederiksen, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
April 1, 1997
Identification of two novel missense mutations in the human OB gene
S M Echwald, S B Rasmussen, T I Sørensen, et al.
Diabetes
|
December 10, 1997
Effect of insulin on GLUT4 cell surface content and turnover rate in human skeletal muscle as measured by the exofacial bis-mannose photolabeling technique
S Lund, G D Holman, J R Zierath, et al.
Diabetologia
|
August 1, 1997
Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3alpha and beta isoforms in patients with NIDDM
L Hansen, K C Arden, S B Rasmussen, et al.
Diabetologia
|
October 13, 2001
Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians
J Ek, G Andersen, S A Urhammer, et al.
Acta Medica Scandinavica. Supplementum
|
January 1, 1984
Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Study design, patient characteristics and conduct of the study
H J Jürgensen, M P Andersen, P Bechsgaard, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 2008
Lack of association of fatness-related FTO gene variants with energy expenditure or physical activity
T Berentzen, S I I Kring, C Holst, et al.
Diabetes, Obesity & Metabolism
|
March 30, 2007
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial
S S Lund, L Tarnow, C D A Stehouwer, et al.
Diabetes Care
|
August 1, 1990
Acute actions of sulfonylurea drugs during long-term treatment of NIDDM
O K Faber, H Beck-Nielsen, C Binder, et al.
Acta Medica Scandinavica. Supplementum
|
January 1, 1984
The effect of long-term intervention with alprenolol on mortality in definite or suspected myocardial infarction
H J Jürgensen, J Frederiksen, M P Andersen, et al.
Page
of 60